Avadel Pharmaceuticals said on Wednesday its board has determined that a sweetened offer from Alkermes was superior to a ...
Shortly after Alkermes and Avadel announced their deal, Lundbeck made an unsolicited offer of $23 per share, including $21 ...
Facing the fact that Lundbeck’s unexpected offer for Avadel Pharmaceuticals was sweeter, Alkermes has come back to the ...
Alkermes (ALKS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Lundbeck had tried to scoop the narcolepsy drug maker out from under Alkeremes with $2.4 billion, but Avadel has elected to ...
Pharmaceutical Technology on MSN
Alkermes prevails over Lundbeck in Avadel bidding war
Alkermes will likely proceed with its planned acquisition of Avadel, which experienced an unexpected hitch following Lundbeck ...
In a statement, Denmark-based Lundbeck said it had carried out a "comprehensive assessment" of the bids on the table for ...
12don MSN
TD Cowen Asserts Buy Rating as Alkermes plc (ALKS) Delivers Topline Results for Narcolepsy Treatment
Alkermes Plc (NASDAQ:ALKS) is one of the best breakout stocks to invest in. On November 12, Alkermes Plc (NASDAQ:ALKS) ...
Avadel Pharmaceuticals (AVDL) stock is in focus as Alkermes (ALKS) ups buyout offer amid a rival bid from the Danish ...
Alkermes plc (Nasdaq: ALKS) ("Alkermes") and Avadel Pharmaceuticals plc (Nasdaq: AVDL) ("Avadel") today announced that the companies have reached agreement on the terms of an increased recommended ...
Alkermes plc (Nasdaq: ALKS) announced today that management will participate in two upcoming investor conferences.
Investor's Business Daily on MSN
Alkermes Ups Its Avadel Bid To $2.37 Billion In A Buyout Battle With Lundbeck
Alkermes upped its bid on Avadel to $2.37 billion on Wednesday, coming in with the "superior proposal" vs. Lundbeck's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback